Are antidepressants overprescribed? No

BMJ (Online)

Volumn 346, Issue 7907, 2013, Pages

  Reid, Ian C ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; PLACEBO;

DEPRESSION; DRUG EFFICACY; DRUG RESPONSE; EVIDENCE BASED MEDICINE; GENERAL PRACTITIONER; HUMAN; INAPPROPRIATE PRESCRIBING; MEDICAL DECISION MAKING; MEDICAL RESEARCH; MORBIDITY; NEUROPATHIC PAIN; NOTE; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOTHERAPY; ARTICLE; CLINICAL PRACTICE; STATISTICS;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; HUMANS; INAPPROPRIATE PRESCRIBING; PHYSICIAN'S PRACTICE PATTERNS;

MLCS; MLOWN;

EID: 84875797953     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f190     Document Type: Note

References (15)

1. Leucht S, Hierl S, Kissling W, Dold M, Davis JM. Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses. Br J Psychiatry 2012;200:97-106.
2. Mitchell AJ, Vaze A, Rao S. Clinical diagnosis of depression in primary care: a meta-analysis. Lancet 2009;374:609-19.
3. Cameron IM, Lawton K, Reid IC. Appropriateness of antidepressant prescribing: an observational study in a Scottish primary-care setting. Br J Gen Pract 2009;59:644-9.
4. Munoz-Arroyo R, Sutton M, Morrison J. Exploring potential explanations for the increase in antidepressant prescribing in Scotland using secondary analyses of routine data. Br J Gen Pract 2006;56:423-8. (Pubitemid 43891224)
5. Moore M, Ming Yuen H, Dunn N, Mullee M, Maskell J, Kendrick T. Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database. BMJ 2009;339:b3999.
6. Lockhart P, Guthrie B. Trends in primary care antidepressant prescribing 1995-2007: a longitudinal population database analysis. Br J Gen Pract 2011;61:e565-72.
7. NHS Scotland. Prescribing and medicines: medicines used in mental health.2012. www.isdscotland.org/Health-Topics/Prescribing-and-Medicines/ Publications/2012-09-25/2012-09-25-Prescribing-MH-Summary.pdf?66003054381.
8. Scottish Parliament, Public Audit Committee third report: overview of mental health services. 2010. http://archive.scottish.parliament.uk/s3/ committees/publicAudit/reports-10/paur10-03.htm.
9. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the food and drug administration. PLoS Med 2008;5:260-8.
10. Fountoulakis KN, Möller HJ. Efficacy of antidepressants: a re-analysis and re-interpretation of the Kirsch data. Int J Neuropsychopharmacol 2011;14:405-12.
11. Penn E, Tracy DK. The drugs don't work? Antidepressants and the current and future pharmacological management of depression. Ther Adv Psychopharmacol 2012;2:179-88.
12. Gibbons RD, Hur K, Brown CH, Davis JM, Mann JJ. Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine. Arch Gen Psychiatry 2012;69:572-9.
13. Robinson P. Depression, ethnicity and talking therapies. Health Serv J 2009 Feb 9. www.chks.co.uk/assets/files/Published%20articles/009-INTEL-090205- final.pdf.
14. Cuijpers P, van Straten A, Bohlmeijer E, Hollon SD, Andersson G. The effects of psychotherapy for adult depression are overestimated: a meta-analysis of study quality and effect size. Psychol Med 2010;40:211-23.
15. Anderson IM, Ferrier IN, Baldwin RC, Cowen PJ, Howard L, Lewis G, et al. Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharm 2008;22:343-96. (Pubitemid 351989984)